New Zealand markets open in 7 hours 40 minutes

ImmunityBio, Inc. (IBRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.15+0.18 (+2.01%)
At close: 04:00PM EDT
9.07 -0.08 (-0.87%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
622
622
240
934
605
Operating expenses
Research development
232,366
232,366
248,149
195,958
139,507
Selling general and administrative
129,620
129,620
102,708
135,256
71,318
Total operating expenses
361,986
361,986
350,857
331,214
210,825
Operating income or loss
-361,364
-361,364
-350,617
-330,280
-210,220
Interest expense
129,198
129,198
63,515
14,849
9,074
Total other income/expenses net
-94,193
-94,193
-5,862
-5,546
-8,464
Income before tax
-583,892
-583,892
-417,286
-349,839
-226,033
Income tax expense
-40
-40
34
9
-1,846
Income from continuing operations
-583,852
-583,852
-417,320
-349,848
-224,187
Net income
-583,196
-583,196
-416,567
-346,790
-221,851
Net income available to common shareholders
-583,196
-583,196
-416,567
-346,790
-221,851
Basic EPS
-1.04
-1.15
-1.04
-0.89
-0.58
Diluted EPS
-1.04
-1.15
-1.04
-0.89
-0.58
Basic average shares
442,157
508,636
399,900
389,234
383,179
Diluted average shares
442,157
508,636
399,900
389,234
383,179